Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Ulcerative Colitis Clinical Trial
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Gut PC, dba Digestive Health Specialists of the Southeast
mi
from
Dothan, AL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Lonestar Endoscopy, LLP (Endoscopy Location)
mi
from
Keller, TX
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase II
Updated: 12/31/1969
NYU Medical Science Building
mi
from
New York, NY
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Sagact Pllc
mi
from
San Antonio, TX
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase II
Updated: 12/31/1969
UMASS Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Dehydration Clinical Trial
The Role of Hydration on Exercise Performance - ODIN
Status: Enrolling
Updated: 12/1/2016
University of Arkansas - HPER
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Cushing's Disease Clinical Trial
Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Pennsylvania Medical Center University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Depressive Disorder, Major Clinical Trial
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
US1369
mi
from
Dothan, AL
Click here to add this to my saved trials
Depressive Disorder, Major Clinical Trial
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
US1118
mi
from
Glendale, CA
Click here to add this to my saved trials
Depressive Disorder, Major Clinical Trial
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
US1123
mi
from
Imperial, CA
Click here to add this to my saved trials
Depressive Disorder, Major Clinical Trial
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
US1261
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Depressive Disorder, Major Clinical Trial
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
US1323
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Depressive Disorder, Major Clinical Trial
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
US1368
mi
from
Orange, CA
Click here to add this to my saved trials
Depressive Disorder, Major Clinical Trial
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
US1308
mi
from
Orem, UT
Click here to add this to my saved trials
Depressive Disorder, Major Clinical Trial
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
US1386
mi
from
Wichita, KS
Click here to add this to my saved trials
Biliary Cirrhosis, Primary Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
Status: Enrolling, Phase
Updated: 12/31/1969
Southern Therapy and Advanced Research (STAR)
mi
from
Jackson, MS
Click here to add this to my saved trials
Biliary Cirrhosis, Primary Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
Status: Enrolling, Phase
Updated: 12/31/1969
Sandra Atlas Bass Center for Liver Diseases
mi
from
Manhasset, NY
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Asheville, NC
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Edgewater, FL
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Roseville, MI
Click here to add this to my saved trials
Amblyopia Clinical Trial
Binocular Dig Rush Game Treatment for Amblyopia
Status: Enrolling, Phase III
Updated: 12/31/1969
Alberta Children's Hospital
mi
from
Calgary,
Click here to add this to my saved trials
Amblyopia Clinical Trial
Binocular Dig Rush Game Treatment for Amblyopia
Status: Enrolling, Phase III
Updated: 12/31/1969
Pediatric Eye Specialists
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Amblyopia Clinical Trial
Binocular Dig Rush Game Treatment for Amblyopia
Status: Enrolling, Phase III
Updated: 12/31/1969
Concord Ophthalmologic Associates
mi
from
Concord, NH
Click here to add this to my saved trials
Amblyopia Clinical Trial
Binocular Dig Rush Game Treatment for Amblyopia
Status: Enrolling, Phase III
Updated: 12/31/1969
Midwestern University Eye Institute
mi
from
Glendale, AZ
Click here to add this to my saved trials
Amblyopia Clinical Trial
Binocular Dig Rush Game Treatment for Amblyopia
Status: Enrolling, Phase III
Updated: 12/31/1969
Western University College of Optometry
mi
from
Pomona, CA
Click here to add this to my saved trials
Amblyopia Clinical Trial
Binocular Dig Rush Game Treatment for Amblyopia
Status: Enrolling, Phase III
Updated: 12/31/1969
U of MO St. Louis College of Optometry
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Amblyopia Clinical Trial
Binocular Dig Rush Game Treatment for Amblyopia
Status: Enrolling, Phase III
Updated: 12/31/1969
Pediatric Eye Associates
mi
from
Wilmette, IL
Click here to add this to my saved trials
Bacterial Infections Clinical Trial
Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium + Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)
Status: Enrolling, Phase III
Updated: 8/8/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Bacterial Infections Clinical Trial
Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium + Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)
Status: Enrolling, Phase III
Updated: 8/8/2017
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Bacterial Infections Clinical Trial
Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium + Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)
Status: Enrolling, Phase III
Updated: 8/8/2017
MSD Brasil
mi
from
Sao Paulo,
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab, an Anti-PD-L1 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Rockville Centre
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Parkinson Disease Psychosis Clinical Trial
A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Keck School of Medicine of USC/ University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Parkinson Disease Psychosis Clinical Trial
A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Florida Parkinson's Disease and Movement Disorder's Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
BCCA-Vancouver Cancer Centre
mi
from
Vancouver,
Click here to add this to my saved trials
Hemophilia A Clinical Trial
BAX 855 Previously Untreated Patient (PUP)
Status: Enrolling, Phase III
Updated: 4/19/2018
Ann & Robert H. Lurie Children's H
mi
from
Chicago, IL
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) Monotherapy in Locally Advanced/Metastatic Renal Cell Carcinoma (MK-3475-427/KEYNOTE-427)
Status: Enrolling, Phase II
Updated: 1/31/2018
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) Monotherapy in Locally Advanced/Metastatic Renal Cell Carcinoma (MK-3475-427/KEYNOTE-427)
Status: Enrolling, Phase II
Updated: 1/31/2018
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Antisocial Behavior Clinical Trial
Multisystemic Therapy-Emerging Adults Trial
Status: Enrolling
Updated: 12/31/1969
North American Family Institute
mi
from
New Haven, CT
Click here to add this to my saved trials
Hodgkin Disease Clinical Trial
A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment
Status: Enrolling, Phase II
Updated: 12/31/1969
UNC Lineberger Cancer Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling, Phase II
Updated: 4/26/2018
Vanda Investigational Site
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling, Phase II
Updated: 4/26/2018
Vanda Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling, Phase II
Updated: 4/26/2018
Vanda Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling, Phase II
Updated: 4/26/2018
Vanda Investigational Site
mi
from
Marrero, LA
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling, Phase II
Updated: 4/26/2018
Vanda Investigational Site
mi
from
Mentor, OH
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling, Phase II
Updated: 4/26/2018
Vanda Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Open-Label, Multicenter, Phase 1/2 Study of Tazemetostat (EZH2 Histone Methyl Transferase [HMT] Inhibitor) as a Single Agent in Subjects With Adv. Solid Tumors or With B-cell Lymphomas and Tazemetostat in Combination With Prednisolone in Subjects With DLBCL
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Clinical Trial
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Mercy Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Clinical Trial
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Caro Cancer Center
mi
from
Caro, MI
Click here to add this to my saved trials
Clinical Trial
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Care Specialists of Illinois - Decatur
mi
from
Decatur, IL
Click here to add this to my saved trials
Clinical Trial
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Cross Cancer Institute
mi
from
Edmonton,
Click here to add this to my saved trials
Clinical Trial
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Aurora Health Care Germantown Health Center
mi
from
Germantown, WI
Click here to add this to my saved trials
Clinical Trial
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Hawaii Cancer Care Inc-POB II
mi
from
Honolulu, HI
Click here to add this to my saved trials
Clinical Trial
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
OptumCare Cancer Care at MountainView
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Clinical Trial
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Centra Lynchburg Hematology Oncology Clinic
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Clinical Trial
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Aurora Bay Area Medical Group-Marinette
mi
from
Marinette, WI
Click here to add this to my saved trials
Clinical Trial
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Medical Center-Ontario
mi
from
Ontario, OR
Click here to add this to my saved trials
Clinical Trial
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Marshfield Clinic Stevens Point Center
mi
from
Stevens Point, WI
Click here to add this to my saved trials
Clinical Trial
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Ann Arbor
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
CHU Saint-Pierre
mi
from
Bruxelles,
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Pali Momi Medical Center
mi
from
'Aiea, HI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
The Cancer Center of Hawaii-Pali Momi
mi
from
'Aiea, HI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Radiology Associates of Appleton/ThedaCare Regional Medical Center
mi
from
Appleton, WI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Austin Cancer Centers-Saint David's
mi
from
Austin, TX
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Mercy Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Aurora Cancer Care-Southern Lakes VLCC
mi
from
Burlington, WI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Mercy Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Newland Medical Associates-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
McLaren Cancer Institute-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
AdventHealth Infusion Center Haywood
mi
from
Clyde, NC
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Integrity Oncology PLLC-Collierville
mi
from
Collierville, TN
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
UM Sylvester Comprehensive Cancer Center at Coral Gables
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Northshore Oncology Associates-Covington
mi
from
Covington, LA
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Southern Cancer Center PC-Daphne
mi
from
Daphne, AL
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
UM Sylvester Comprehensive Cancer Center at Deerfield Beach
mi
from
Deerfield Beach, FL
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Ascension Saint John Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health Saint Mary's - Detroit Lakes Clinic
mi
from
Detroit Lakes, MN
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Union Hospital of Cecil County
mi
from
Elkton, MD
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Walter Knox Memorial Hospital
mi
from
Emmett, ID
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
IMG Hematology Oncology 8501
mi
from
Fairfax, VA
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
INOVA Fair Oaks Hospital
mi
from
Fairfax, VA
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Genesee Hematology Oncology PC
mi
from
Flint, MI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Rex Hematology Oncology Associates-Garner
mi
from
Garner, NC
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Saint Mary's
mi
from
Green Bay, WI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan Breast Specialists-Grosse Pointe Woods
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Lehigh Valley Hospital-Hazleton
mi
from
Hazleton, PA
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Cancer Care Inc-Liliha
mi
from
Honolulu, HI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Community Cancer Center East
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Baptist MD Anderson Cancer Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
OptumCare Cancer Care at Fort Apache
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Marshfield Medical Center-Marshfield
mi
from
Marshfield, WI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Southern Cancer Center PC-Springhill
mi
from
Mobile, AL
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
ProHealth D N Greenwald Center
mi
from
Mukwonago, WI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Baptist Memorial Hospital and Cancer Center-Union County
mi
from
New Albany, MS
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Lakeland Hospital Niles
mi
from
Niles, MI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
ProHealth Oconomowoc Memorial Hospital
mi
from
Oconomowoc, WI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Kansas Hospital-Indian Creek Campus
mi
from
Overland Park, KS
Click here to add this to my saved trials